New nerve pain drug tested in humans for first time
NCT ID NCT07586514
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested a new drug called 4ET1103 in 40 healthy volunteers to see if it is safe and how the body processes it. Each person received a single dose of either the drug or a placebo. The goal was to check for side effects and measure drug levels, not to treat pain. This is a first step before testing in people with nerve pain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROPATHIC PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
PPD
Austin, Texas, 78744, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a skin injection of ketamine and lidocaine tame CRPS pain?
- Could painkillers quietly disrupt your hormones?
- Alzheimer's drug may stop chronic pain after breast surgery
- Pepper-Based patch tested against Kids' chronic nerve pain
- Could a botox shot in the mouth silence stubborn nerve pain?
- Zapping pain without drugs: brain stimulation put to the test for nerve pain